5-methylcytosine regulated CCNL2 promotes tumorigenesis and cisplatin resistance of ovarian cancer with therapeutic implications

Authors

Institutions

Publication Details

Journal
Journal of Ovarian Research
Published
2025-07-24
DOI
https://doi.org/10.1186/s13048-025-01753-9
Citations
3
Primary Topic
RNA modifications and cancer
Type
article
Field-Weighted Citation Impact
2.42

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

5-methylcytosine regulated CCNL2 promotes tumorigenesis and cisplatin resistance of ovarian cancer with therapeutic implications

Shu Yao, Guiyun Cheng, Xihan Liu, Beihua Kong et al.
3 citations
Journal of Ovarian Research
RNA modifications and cancer
2.42
article

5-methylcytosine regulated CCNL2 promotes tumorigenesis and cisplatin resistance of ovarian cancer with therapeutic implications

Shu Yao, Guiyun Cheng, Xihan Liu, Beihua Kong, Wenwen Jiang, Kai Zhang
article en
3 citations

Abstract

No abstract available for this paper.
Journal of Ovarian ResearchVol. 18(1)
Qilu Hospital of Shandong University (CN)
Natural Science Foundation of Shandong Province
Good health and well-being
Openalex Percentile: Top 11%
RNA modifications and cancer
2.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.